LODC
OCGN icon

Lanham O'Dell & Company’s Ocugen OCGN Stock Holding History

Lanham O'Dell & Company’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$135K Sell
100,000
-40,000
-29% -$57K 0.04% 40
2025
Q3 		$228K Buy
140,000
+10,000
+8% +$11.1K 0.07% 35
2025
Q2 		$126K Buy
130,000
+14,000
+12% +$11.6K 0.05% 40
2025
Q1 		$81.9K Buy
+116,000
New +$80.2K 0.05% 32
2024
Q2 		– Sell
-23,050
Closed -$37.8K – 27
2024
Q1 		$37.8K Buy
23,050
+12,000
+109% +$10.1K 0.02% 28
2023
Q4 		$6.35K Buy
+11,050
New +$4.43K ﹤0.01% 31
2023
Q1 		– Sell
-10,050
Closed -$13.1K – 21
2022
Q4 		$13.1K Buy
+10,050
New +$15.7K 0.03% 18

Other funds holding OCGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lanham O'Dell & Company's OCGN Position: Q4 2025 in Review

Lanham O'Dell & Company reduced its Ocugen (OCGN) stake by 29% in Q4 2025, selling an estimated $57K and leaving 100,000 shares worth $135K. The position accounts for 0.04% of the portfolio, ranked #40.

Lanham O'Dell & Company first reported a position in OCGN in Q4 2022 and has held it in 7 quarters since. The position peaked at $228K in Q3 2025. 109 funds tracked by Wall St. Rank hold OCGN as of Q4 2025.

  • Lanham O'Dell & Company held 100,000 shares of Ocugen worth $135K as of Q4 2025.
  • Lanham O'Dell & Company sold 40,000 Ocugen shares in Q4 2025, an estimated $57K.
  • Ocugen made up 0.04% of Lanham O'Dell & Company's portfolio in Q4 2025, its #40 holding.
  • Lanham O'Dell & Company first reported a position in Ocugen in Q4 2022 and has held it in 7 quarters since.
  • Lanham O'Dell & Company's Ocugen position peaked at $228K in Q3 2025.
  • 109 funds tracked by Wall St. Rank held Ocugen as of Q4 2025.

Based on Lanham O'Dell & Company's 13F filing for Q4 2025, filed 12 Jan 2026.